| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/25/2001 | EP1117797A2 Rna-associated proteins |
| 07/25/2001 | EP1117796A2 Calcium channel alpha-2/delta gene |
| 07/25/2001 | EP1117795A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 07/25/2001 | EP1117794A2 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 |
| 07/25/2001 | EP1117793A2 Secretory protein - zsig48 |
| 07/25/2001 | EP1117792A2 Bone marrow-derived serum proteins |
| 07/25/2001 | EP1117791A2 Cancer associated antigens and uses therefor |
| 07/25/2001 | EP1117790A2 Human carbohydrate-associated proteins |
| 07/25/2001 | EP1117789A2 Synthetic peptides having fgf receptor affinity |
| 07/25/2001 | EP1117788A1 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117784A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 07/25/2001 | EP1117781A2 Human membrane channel proteins |
| 07/25/2001 | EP1117779A1 $i(MORAXELLA CATARRHALIS) PROTEIN, NUCLEIC ACID SEQUENCE AND USES THEREOF |
| 07/25/2001 | EP1117778A2 Methods and compositions for inducing differentiation and apoptosis in cells that overexpress the notch protein |
| 07/25/2001 | EP1117775A2 Tissue binding peptides, identification, production and utilization thereof |
| 07/25/2001 | EP1117772A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 07/25/2001 | EP1117769A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 07/25/2001 | EP1117765A2 Stem cells bearing an fgf receptor on the cell surface |
| 07/25/2001 | EP1117762A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 07/25/2001 | EP1117692A1 Tie2 agonist antibodies |
| 07/25/2001 | EP1117690A1 Polymeric hemoglobin mutants |
| 07/25/2001 | EP1117689A1 Bone morphogenetic protein antagonists based on the mature protein |
| 07/25/2001 | EP1117687A2 Compositions and methods for wt1 specific immunotherapy |
| 07/25/2001 | EP1117685A1 Treatment of inflammatory disease |
| 07/25/2001 | EP1117684A1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure |
| 07/25/2001 | EP1117682A1 Novel peptides |
| 07/25/2001 | EP1117681A1 Novel peptides |
| 07/25/2001 | EP1117680A2 Ncam binding compounds |
| 07/25/2001 | EP1117679A2 Tumor antigens and ctl clones isolated by a novel procedure |
| 07/25/2001 | EP1117677A1 Ligand presenting assembly (lpa), method of preparation and uses thereof |
| 07/25/2001 | EP1117675A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 07/25/2001 | EP1117673A1 Mammaglobin, a secreted mammary-specific breast cancer protein |
| 07/25/2001 | EP1117660A1 Thrombin inhibitors |
| 07/25/2001 | EP1117645A1 Aryl-substituted propanolamine derivatives, methods for their production, medicaments containing said compounds and their use |
| 07/25/2001 | EP1117444A2 Hydrogels and water soluble polymeric carriers for drug delivery |
| 07/25/2001 | EP1117443A1 Peptide-based carrier devices for stellate cells |
| 07/25/2001 | EP1117439A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 07/25/2001 | EP1117438A1 Tie2 antagonist antibodies |
| 07/25/2001 | EP1117437A1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 07/25/2001 | EP1117436A1 Neisseria spp polypeptide, nucleic acid sequence and uses thereof |
| 07/25/2001 | EP1117429A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes |
| 07/25/2001 | EP1117428A2 Compositions and methods for inhibiting angiogenesis |
| 07/25/2001 | EP1117427A2 USE OF $i(PEX) IN THE TREATMENT OF METABOLIC BONE DISEASES |
| 07/25/2001 | EP1117426A2 Akt compositions for enhancing survival of cells |
| 07/25/2001 | EP1117425A2 Methods for the treatment of non-thyroid disorders |
| 07/25/2001 | EP1117424A2 Null igf for the treatment of cancer |
| 07/25/2001 | EP1117422A1 Repair of larynx, trachea, and other fibrocartilaginous tissues |
| 07/25/2001 | EP1117420A1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 07/25/2001 | EP1117419A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 07/25/2001 | EP1117416A1 Plant extracts for the treatment of increased bone resorption |
| 07/25/2001 | EP1117413A1 Transplantation of neural cells for the treatment of chronic pain or spasticity |
| 07/25/2001 | EP1117393A2 Use of acylcarnitines as antitumour agents |
| 07/25/2001 | EP1117388A1 Antioxidant gel for gingival conditions |
| 07/25/2001 | EP1117383A1 Dosage form comprising therapeutic formulation |
| 07/25/2001 | EP1117378A2 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 07/25/2001 | EP0826004B1 Storage stable hemoglobin solutions |
| 07/25/2001 | EP0726778B1 Oral delivery system of chemically modified proteins g-csf |
| 07/25/2001 | EP0722338B1 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 07/25/2001 | EP0708657B1 Compositions for nasal administration of desmopressin |
| 07/25/2001 | EP0684944B1 Coupling product obtained from hystamine and an amino acid |
| 07/25/2001 | EP0674525B1 Aqueous pharmaceutical preparations of g-csf with a long shelf life |
| 07/25/2001 | EP0642357B1 Radiolabelled somatostatin |
| 07/25/2001 | EP0585444B1 Hepatoma treatment with somatostatin analogs |
| 07/25/2001 | EP0577605B1 G protein-coupled glutamate receptors |
| 07/25/2001 | CN1305589A Improved immunodiagnostic assays using reducing agents |
| 07/25/2001 | CN1305527A Vasculogenesis correlation molecule |
| 07/25/2001 | CN1305526A Gene coding for heliomicine and use thereof |
| 07/25/2001 | CN1305525A Phagocytic assay method |
| 07/25/2001 | CN1305498A Peptide composition as immunogen for treatment of allergy |
| 07/25/2001 | CN1305497A Monoclonal antibodies directed against the G3BP protein and use |
| 07/25/2001 | CN1305496A Cyclic somatostatin analogs |
| 07/25/2001 | CN1305495A Peptide |
| 07/25/2001 | CN1305494A Antithrombotic compounds |
| 07/25/2001 | CN1305493A Novel cyclosporins |
| 07/25/2001 | CN1305492A Phrazinone protease inhibitors |
| 07/25/2001 | CN1305491A Crystalline forms of 1S-[1a(pha(2S, 3R), 9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl)carbonyl]-amino] actahydro-6H-piridazino [1,2-A][1,2] diazepin-1-carboxamide |
| 07/25/2001 | CN1305487A Benzo (b) thiepine-1, 1-dioxide derivatives, method for production thereof, medicaments containing these compounds and their use |
| 07/25/2001 | CN1305469A Benzothiepine-1, 1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 07/25/2001 | CN1305387A Enhancement of antibody-cytokine fusion protein medicated immune responses by co-administration with prostaglandin inhibitor |
| 07/25/2001 | CN1305386A Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 07/25/2001 | CN1305383A Regulation of tyrosine bydroxylase |
| 07/25/2001 | CN1305382A Use of PEG-IFN-alpha and triazole nucleoside for treatment of chronic hepatitis C |
| 07/25/2001 | CN1305373A Therapeutic combinations comprising selective estrofen receptor modulator and parathyroid hormone |
| 07/25/2001 | CN1305108A Medicine screen model for screening and evaluating activity of thrombocyte and process for preparing reagent and medicine respectively for diagnosing and treating thrombocyte disease |
| 07/25/2001 | CN1305003A Gene engineering process for preparing died/tried fusion protein of erythrocyte growth factor with improved bioactivity |
| 07/25/2001 | CN1304772A Process for preparing medicine to treating diseases in peripheral nerve system and male genetic defect |
| 07/25/2001 | CN1068793C Ostenogenesis stimulin injection and its preparing process |
| 07/25/2001 | CN1068792C Lycium chinese glycopeptide and its production process |
| 07/24/2001 | US6265572 Inhibit binding of integrin expressing cells to cell adhesion molecules of endothelium |
| 07/24/2001 | US6265567 Isolated FrpB nucleic acid molecule |
| 07/24/2001 | US6265564 Expressed ligand-vascular intercellular signalling molecule |
| 07/24/2001 | US6265562 Nucleotide sequences coding transcription factor; for the treatment and prevention of infection, tumors, leukemias, autoimmune disease, allergies, arthritis, inflammation, organ rejection, graft versus host disease and coagulation defects |
| 07/24/2001 | US6265560 Nucleotide sequences coding enzymatic polypeptide associated with signal transducton; for diagnosis, prevention, and treatment of inflammation, arthritis and physiological defects |
| 07/24/2001 | US6265558 Compound of linked nucleosides having thiol group attatched at 5-pyrimidine or 2-, 6-, or 8-purine positions; attachment reporter molecules, reporter enzymes, steroids, lipophilic molecules, peptides, proteins and other groups |
| 07/24/2001 | US6265556 Nucleotide sequences coding mammalian polypeptide associated with immune response and cell propagation; for the detection of modulators of apoptosis |
| 07/24/2001 | US6265552 Immobilization of protein on surface; transform cell with vector, culture cells, isolate immobilized fusion protein from prepared surface |
| 07/24/2001 | US6265551 Form of dipeptidylpeptidase IV (CD26) found in human serum, antibodies thereto, and uses thereof |
| 07/24/2001 | US6265550 Antibody; for use in the diagnosis, prevention, and treatment of cancer, inflammation, and insulin response defects |
| 07/24/2001 | US6265549 Monoclonal antibody; for use in the treatment of inflammation |